高级检索
当前位置: 首页 > 详情页

Identification of an individualized autophagy prognostic index in clear cell renal cell carcinoma patients

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Immuno-Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China [2]Department of Oncology, Affiliated Xingtai People’s Hospital of Hebei Medical University, Xingtai 054001, China [3]Department of Urology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China [4]School of Basic Medical Sciences, Hebei Medical University, Shijiazhuang 050017, China [5]Department of Orthopedics, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China
出处:
ISSN:

关键词: The Cancer Genome Atlas (TCGA) clear cell renal cell carcinoma (ccRCC) autophagy-related genes (ARGs) prognostic index (PI)

摘要:
Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancer. ccRCC arises from the proximal tubular epithelium and is associated with high mortality. Autophagy may either promote or suppress tumor cell survival at different stages of cancer development. It is essential to investigate the association between autophagy-related genes (ARGs) and prognosis in ccRCC patients. We used datasets obtained from The Cancer Genome Atlas (TCGA) database to identify the expression level of ARGs in ccRCC patients. Functional enrichment and Kyoto Encyclopedia of Genes and Genomes (K EGG) analyses were performed using Metascape database. Hub genes were identified by Cytoscape software. We constructed a Cox proportional hazard regression model to identify hub genes that are significantly associated with overall survival (OS) in ccRCC patients. Subsequently, a prognostic index (PI) was calculated and ccRCC patients were stratified into high-risk and low-risk groups based on a median PI value. Our study detected several altered ARGs in ccRCC, which could be a useful prognostic tool in ccRCC patients.

语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2020]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
JCR分区:
出版当年[2020]版:
Q4 ONCOLOGY
最新[2023]版:
Q4 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Department of Immuno-Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China [2]Department of Oncology, Affiliated Xingtai People’s Hospital of Hebei Medical University, Xingtai 054001, China
通讯作者:
通讯机构: [1]Department of Immuno-Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China [*1]Department of Immuno-Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39766 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号